关注
Eric Ciamporcero
Eric Ciamporcero
Octimet Oncology
在 octimet.com 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Interaction of aldehydes derived from lipid peroxidation and membrane proteins
S Pizzimenti, E Ciamporcero, M Daga, P Pettazzoni, A Arcaro, ...
Frontiers in physiology 4, 242, 2013
3612013
Drug delivery nanoparticles in skin cancers
C Dianzani, GP Zara, G Maina, P Pettazzoni, S Pizzimenti, F Rossi, ...
BioMed research international 2014 (1), 895986, 2014
1832014
Dietary protein restriction inhibits tumor growth in human xenograft models of prostate and breast cancer
L Fontana, RM Adelaiye, AL Rastelli, KM Miles, E Ciamporcero, ...
Oncotarget 4 (12), 2451, 2013
1492013
Role of 4-hydroxynonenal-protein adducts in human diseases
G Barrera, S Pizzimenti, ES Ciamporcero, M Daga, C Ullio, A Arcaro, ...
Antioxidants & redox signaling 22 (18), 1681-1702, 2015
1332015
YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage
E Ciamporcero, H Shen, S Ramakrishnan, S Yu Ku, S Chintala, L Shen, ...
Oncogene 35 (12), 1541-1553, 2016
1272016
Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models
E Ciamporcero, KM Miles, R Adelaiye, S Ramakrishnan, L Shen, SY Ku, ...
Molecular cancer therapeutics 14 (1), 101-110, 2015
1082015
Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models
L Shen, A Sundstedt, M Ciesielski, KM Miles, M Celander, R Adelaiye, ...
Cancer immunology research 3 (2), 136-148, 2015
1012015
Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells
R Minelli, R Cavalli, L Ellis, P Pettazzoni, F Trotta, E Ciamporcero, ...
European journal of pharmaceutical sciences 47 (4), 686-694, 2012
892012
GSH-targeted nanosponges increase doxorubicin-induced toxicity “in vitro” and “in vivo” in cancer cells with high antioxidant defenses
M Daga, C Ullio, M Argenziano, C Dianzani, R Cavalli, F Trotta, C Ferretti, ...
Free Radical Biology and Medicine 97, 24-37, 2016
872016
EZH2 modifies sunitinib resistance in renal cell carcinoma by kinome reprogramming
R Adelaiye-Ogala, J Budka, NP Damayanti, J Arrington, M Ferris, CC Hsu, ...
Cancer research 77 (23), 6651-6666, 2017
732017
Sunitinib dose escalation overcomes transient resistance in clear cell renal cell carcinoma and is associated with epigenetic modifications
R Adelaiye, E Ciamporcero, KM Miles, P Sotomayor, J Bard, M Tsompana, ...
Molecular cancer therapeutics 14 (2), 513-522, 2015
702015
Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer
E Ciamporcero, M Daga, S Pizzimenti, A Roetto, C Dianzani, ...
Free Radical Biology and Medicine 115, 447-457, 2018
692018
Dll4 blockade potentiates the anti-tumor effects of VEGF inhibition in renal cell carcinoma patient-derived xenografts
KM Miles, M Seshadri, E Ciamporcero, R Adelaiye, B Gillard, ...
PloS one 9 (11), e112371, 2014
662014
Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells
P Pettazzoni, S Pizzimenti, C Toaldo, P Sotomayor, L Tagliavacca, S Liu, ...
Free Radical Biology and Medicine 50 (2), 313-322, 2011
642011
HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma
S Ramakrishnan, SY Ku, E Ciamporcero, KM Miles, K Attwood, S Chintala, ...
BMC cancer 16, 1-15, 2016
552016
Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells
P Pettazzoni, E Ciamporcero, C Medana, S Pizzimenti, F Dal Bello, ...
Free Radical Biology and Medicine 51 (8), 1610-1618, 2011
362011
Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts
L Wei, S Chintala, E Ciamporcero, S Ramakrishnan, M Elbanna, J Wang, ...
Oncotarget 7 (47), 76374, 2016
352016
Rosiglitazone and AS601245 decrease cell adhesion and migration through modulation of specific gene expression in human colon cancer cells
A Cerbone, C Toaldo, R Minelli, E Ciamporcero, S Pizzimenti, ...
PLoS One 7 (6), e40149, 2012
312012
PPARγ in coronary atherosclerosis: in vivo expression pattern and correlations with hyperlipidemic status and statin treatment
A Pucci, L Formato, M Muscio, E Brscic, S Pizzimenti, F Ferroni, ...
Atherosclerosis 218 (2), 479-485, 2011
312011
AS601245, an anti‐inflammatory JNK inhibitor, and Clofibrate have a synergistic effect in inducing cell responses and in affecting the gene expression profile in CaCo‐2 colon …
A Cerbone, C Toaldo, S Pizzimenti, P Pettazzoni, C Dianzani, R Minelli, ...
PPAR research 2012 (1), 269751, 2012
302012
系统目前无法执行此操作,请稍后再试。
文章 1–20